Bio Plus Co., Ltd (KOSDAQ:099430)
South Korea · Delayed Price · Currency is KRW 3,220.00
0.00 (0.00%)
Sep 11, 2026, 3:30 PM KST
Bio Plus Market Cap
Bio Plus has a market cap or net worth of 198.16 billion as of September 11, 2026. Its market cap has decreased by -45.39% in one year.
Market Cap
198.16B
Enterprise Value
256.36B
Revenue
99.15B
Ranking
n/a
PE Ratio
20.67
Stock Price
3,220.00
ChartMarket Cap Chart
Since September 27, 2021, Bio Plus's market cap has decreased from 451.40B to 198.16B, a decrease of -56.10%. That is a compound annual growth rate of -15.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 198.16B | -35.98% |
| Dec 30, 2025 | 309.55B | -24.79% |
| Dec 30, 2024 | 411.57B | 4.76% |
| Dec 28, 2023 | 392.88B | -2.28% |
| Dec 29, 2022 | 402.04B | 1.78% |
| Dec 30, 2021 | 395.00B | -12.50% |
| Sep 27, 2021 | 451.40B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| WON TECH | 436.74B |
| Samyang Biopharm | 364.36B |
| Curexo | 333.79B |
| ToolGen | 304.04B |
| Value Added Technology | 267.08B |
| JETEMA, | 244.23B |
| Vieworks | 230.99B |
| Boditech Med | 197.96B |